TIANJIN TEDA BIOMEDICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 8189 for the last semiannual is 229.12 M HKD, and it's 8.97% higher compared to the previous semiannual. The net income of H2 23 is -9.63 M HKD.